Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbial metabolites alter IgA immunity in type 1 diabetes
Juan Huang, James A. Pearson, Jian Peng, et al.
JCI Insight (2020) Vol. 5, Iss. 10
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Short-chain fatty acids: linking diet, the microbiome and immunity
Elizabeth R. Mann, Ying Ka Lam, Holm H. Uhlig
Nature reviews. Immunology (2024) Vol. 24, Iss. 8, pp. 577-595
Closed Access | Times Cited: 258
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Huiqin Hou, Danfeng Chen, Kexin Zhang, et al.
Cancer Letters (2021) Vol. 526, pp. 225-235
Closed Access | Times Cited: 158
Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity
Chang H. Kim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 341-350
Closed Access | Times Cited: 139
Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation
Kirstine J. Bell, Sonia Saad, Bree J. Tillett, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 79
Gut Microbiome and Neuroinflammation in Hypertension
Elaine M. Richards, Jing Li, Bruce R. Stevens, et al.
Circulation Research (2022) Vol. 130, Iss. 3, pp. 401-417
Open Access | Times Cited: 77
Short chain fatty acids, a possible treatment option for autoimmune diseases
Faezeh Golpour, Mehrsa Abbasi-Alaei, Fatemeh Babaei, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114763-114763
Open Access | Times Cited: 58
Fecal microbiota transplantation: Emerging applications in autoimmune diseases
Ruixue Yang, Zhenzhen Chen, Jun Cai
Journal of Autoimmunity (2023) Vol. 141, pp. 103038-103038
Open Access | Times Cited: 52
Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases
Ashkan Rasouli‐Saravani, Kasra Jahankhani, Shadi Moradi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114620-114620
Open Access | Times Cited: 49
Regulation of CD4+ and CD8+ T Cell Biology by Short-Chain Fatty Acids and Its Relevance for Autoimmune Pathology
Carmen Schiweck, Sharmili Edwin Thanarajah, Mareike Aichholzer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8272-8272
Open Access | Times Cited: 42
Astragalus polysaccharides alleviate type 1 diabetes via modulating gut microbiota in mice
Bing Yang, Zhiwei Xiong, Meng Lin, et al.
International Journal of Biological Macromolecules (2023) Vol. 234, pp. 123767-123767
Closed Access | Times Cited: 30
IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
Ya-ting Du, Cheng Tingzhu, Chenxuan Liu, et al.
Diagnostics (2023) Vol. 13, Iss. 2, pp. 303-303
Open Access | Times Cited: 27
New insights into the role of immunity and inflammation in diabetic kidney disease in the omics era
Xinrong Hu, Sixiu Chen, Siyang Ye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 10
Dietary emulsifier consumption accelerates type 1 diabetes development in NOD mice
Clara Delaroque, Benoît Chassaing
npj Biofilms and Microbiomes (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes
Lente Blok, Nordin M.J. Hanssen, Max Nieuwdorp, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 138-138
Open Access | Times Cited: 1
Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies
Jiawei He, Shufeng Zhou, Jicheng Lv, et al.
Theranostics (2020) Vol. 10, Iss. 25, pp. 11462-11478
Open Access | Times Cited: 68
Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes
Qiyu Yang, Jing Ouyang, Fengjun Sun, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 60
Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
Qing Fang, Na Liu, Binjie Zheng, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 48
Bifidobacterium lactis BL-99 protects mice with osteoporosis caused by colitis via gut inflammation and gut microbiota regulation
Hui Lan, Wei‐Hsien Liu, Hanying Zheng, et al.
Food & Function (2022) Vol. 13, Iss. 3, pp. 1482-1494
Closed Access | Times Cited: 32
Gut Microbial Metabolites on Host Immune Responses in Health and Disease
Jong-Hwi Yoon, Jun-Soo Do, Priyanka Velankanni, et al.
Immune Network (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Role of short‐chain fatty acids in host physiology
Mingyue Liu, Yubo Lu, Guoyu Xue, et al.
Animal Models and Experimental Medicine (2024) Vol. 7, Iss. 5, pp. 641-652
Open Access | Times Cited: 8
Crosstalk between circadian rhythms and the microbiota
James A. Pearson, F. Susan Wong, Wen Li
Immunology (2020) Vol. 161, Iss. 4, pp. 278-290
Open Access | Times Cited: 42
Alcohol Consumption in Rheumatoid Arthritis: A Path through the Immune System
Vugar Azizov, Mario M. Zaiss
Nutrients (2021) Vol. 13, Iss. 4, pp. 1324-1324
Open Access | Times Cited: 33
The Role of Nutritional Factors in the Modulation of the Composition of the Gut Microbiota in People with Autoimmune Diabetes
Anna Winiarska‐Mieczan, Ewa Tomaszewska, Janine Donaldson, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2498-2498
Open Access | Times Cited: 23
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top